Elite Pharmaceuticals, Inc. Debt Conversion, Converted Instrument, Amount
Elite Pharmaceuticals, Inc. (ELTP) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2016-03-31, per its 10-K filed 2016-06-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-06-15
- Elite Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2016 was $0.00.
- Elite Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Elite Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $600.00K.
- Elite Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2013 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|
| 2016-03-31 | $0.00 10-K · filed 2016-06-15 | ||
| 2015-03-31 | $0.00 10-K · filed 2016-06-15 | ||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-15 | $600.00K 10-K · filed 2016-06-15 | |
| 2013-12-31 | $600.00K 10-Q · filed 2014-02-14 | ||
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 |